When we transplanted 1 million CD8+ T cells from WT mice and treated with 0.5 million CD25+FOXP3+ Tregs from WT mice, recipient mice were not protected from developing GVHD, although they cleared tumour cells. This evidence concerns the gene CD8A and graft versus host disease.